Equity
€183,857 ▲ 0.2%
FARMA KOERSEL has made a profit without a break since 2013.
FARMA KOERSEL
Lifetime
20 annual accounts with figures on one time axis, 32 filings since 1994peak €295,246 (2022)
€239,953▼ 13.5%
lowest -€193,002 (2012)
€206,147▲ 98.6%
peak €195,037 (2011)
€183,857▲ 0.2%
€1.4m▼ 22.0%
peak 1.3 FTE (2006)
0.1 FTEunchanged
Board2 names since 2012
2 directors and 1 other
Owners
100%
Documentsfilings and deeds
06-08-20266 days late
2025abbreviated format
Gross margin from €277,251 to €239,953Result from €103,821 to €206,147Debts from €1.9m to €1.4mCash from €27,092 to €111,575
Key points
from the 2025 annual accountsResult
€206,147 ▲ 98.6%
The result rose in 2025 from €103,821 to €206,147.
Turnover
≈ €1.1m estimated
The accounts state no turnover.
Debts
€1.4m 89% of the balance sheet
Financial debts 57%Suppliers 22%Taxes and wages 0%Other 21%
Of this, €748,292 falls due within a year.
Filings
32 annual accounts since 1994
Seven of the last ten came late. The 2019 accounts came latest: 62 days after the end of the period.
Position in the sector
€206,147
Higher net result than 86% of companies in retail trade. Sector median €37,956 · 13,243 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,820 companies had the same profile as FARMA KOERSEL has now. Each dot stands for 10 companies, two years later.
95.1%
were still trading
3.8%
stopped another way
1.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,820 companies, not a prediction for FARMA KOERSEL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Managing director,
Director, since 04-10-2012
- 100%equity €1.2m (2025) · 30-06-2025 annual accounts of
Recent changes
1 director appointed, 2 reappointments
Reappointments: and · Permanent representative: · Appointment: (managing director) · General meeting of 01-09-2024 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0452491241
Purpose change
“De exploitatie,huur en verhuur van één of meer apotheken; Het verzorgen van vervangingen van en voor één of…” (deed in Dutch) · General meeting of 12-05-2022 · Gazette deed
2 directors reappointed
(managing director) and · Permanent representative: · General meeting of 04-10-2018 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| FARMA KOERSEL Beringen | €1.6m | €239,953 | 11.3% | 0.1 |
| APOTHEEK BORMANS BOVELINGEN Heers | €1.3m | €207,810 | 6.1% | 0.2 |
| APOTHEEK COSSEY-HOUSSIN Wevelgem | €1.6m | €253,087 | 21.7% | 0 |
| APOTHEEK BEELE-LAMOTE Wevelgem | €1.4m | €212,256 | 57.2% | 0.2 |
| FAMARO Tongeren-Borgloon | €1.2m | €190,250 | 89.3% | 0 |
| APOTHEEK VAN DAMME Bruges | €1.6m | €230,995 | 33.7% | 0.3 |
| DEN APOTHEKER Boutersem | €1.7m | €250,259 | 71.2% | 0 |
These companies have the same main activity as FARMA KOERSEL: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.2m and €1.7m, founded between 1983 and 2004.
Official details
Source: KBO- Status
- Active since 07-04-1994Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Establishment unit
- 2.066.911.0383582 Beringen, since 25-05-1994
- Financial year end
- 31 December
- Peppol
- Reachable since 22-11-2023
Insights on FARMA KOERSEL
FARMA KOERSEL files the abbreviated format. That format states no turnover. The gross margin rose from €112,181 in 2006 to €239,953 in 2025.
holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about FARMA KOERSEL
- What is the company number of FARMA KOERSEL?
- The company number of FARMA KOERSEL is 0452.491.241. The VAT number is the same number with BE in front: BE 0452.491.241.
- Where is FARMA KOERSEL based?
- The registered office is at Bredestraat 2, 3582 Beringen.Company details
- What does FARMA KOERSEL do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of FARMA KOERSEL?
- FARMA KOERSEL is a public limited company (NV).
- When was FARMA KOERSEL founded?
- FARMA KOERSEL was founded on 07-04-1994.
- Is FARMA KOERSEL still active?
- Yes, FARMA KOERSEL is an active enterprise in the KBO register.
- How many employees does FARMA KOERSEL have?
- FARMA KOERSEL had an average of 0.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of FARMA KOERSEL?
- The turnover in financial year 2025 is ≈ €1.1m. This figure is estimated from the gross margin of €239,953 and 43 comparable companies (NACE 477). It probably lies between €740,000 and €2.4m.
- Is FARMA KOERSEL profitable?
- In financial year 2025, FARMA KOERSEL made a profit of €206,147.
- Where can I find the annual accounts of FARMA KOERSEL?
- FARMA KOERSEL filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of FARMA KOERSEL due?
- FARMA KOERSEL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.